Guohao Xia

LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1

Jiayuan Huang, Banzhou Pan, Guohao Xia et al. · Cell Death and Disease · 2020 · 68 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Phase I dose escalation and pharmacokinetic study on the nanoparticle formulation of polymeric micellar paclitaxel for injection in patients with advanced solid malignancies

Meiqi Shi, Jing Sun, Jinsong Zhou et al. · Investigational New Drugs · 2017 · 30 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial

Yuankai Shi, Jian Fang, Ligang Xing et al. · Nature Medicine · 2025 · 28 citations

Medicine, Molecular Genetics, Oncology +13

Clinical Investigation of Efficacy of Albumin Bound Paclitaxel plus Platinum Compounds as First-line Chemotherapy for Stage III/IV Squamous Non-small Cell Lung Cancer

Ying Fang, Li Wang, Guohao Xia et al. · Asian Pacific Journal of Cancer Prevention · 2014 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Role of the stromal cell derived factor-1/CXC chemokine receptor 4 axis in the invasion and metastasis of lung cancer and mechanism

Yun Zeng, Xinwei Wang, Bijian Yin et al. · Journal of Thoracic Disease · 2017 · 19 citations · Full text

Medicine, Cancer Biology, Oncology +15